Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Progyny (PGNY)
NASDAQ:PGNY
Progyny (PGNY) Stock Price & Analysis
540 Followers
PGNY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$23.90 - $44.95
Previous Close$28.09
Volume1.26M
Average Volume (3M)1.11M
Market Cap
$2.67B
Enterprise Value$2.32B
Total Cash (Recent Filing)$371.09M
Total Debt (Recent Filing)$17.24M
Price to Earnings (P/E)46.2
Beta1.40
Next Earnings
Aug 01, 2024EPS Estimate
$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.61
Shares Outstanding95,220,688
10 Day Avg. Volume2,179,120
30 Day Avg. Volume1,106,401
Standard Deviation0.17
R-Squared0.25
Alpha0.00818
Financial Highlights & Ratios
Price to Book (P/B)4.78
Price to Sales (P/S)2.46
Price to Cash Flow (P/CF)26.00
P/FCF Ratio26.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.13
Enterprise Value/Gross Profit9.72
Enterprise Value/Ebitda68.54
Forecast
1Y Price Target
$37.75Price Target Upside34.39% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Progyny News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceAnalyst maintains a Buy rating with a price objective of 37.00 USD, reflecting confidence in the company's financial prospects.
Market Expansion PotentialThe company has only around 17% of the Fortune 500 companies as clients, suggesting room for growth in a large total addressable market.
Product Demand And GrowthThe long term demand for fertility benefits is not seen as structurally broken, indicating confidence in the market's resilience and the company's growth potential.
Bears Say
Earnings Guidance2024 revenue and Adj. EBITDA guidance were lowered, indicating potential challenges ahead.
Financial PerformanceProgyny's utilization slowdown at the end of 1Q led to the 1Q miss and underlies the lower guidance, creating uncertainty in growth rates.
Market ExpectationsThe shift in forecasts indicates a previous valuation paradigm as incorrect, impacting investor confidence.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PGNY FAQ
What was Progyny’s price range in the past 12 months?
Progyny lowest stock price was $23.90 and its highest was $44.95 in the past 12 months.
What is Progyny’s market cap?
Currently, no data Available
When is Progyny’s upcoming earnings report date?
Progyny’s upcoming earnings report date is Aug 01, 2024 which is in 73 days.
How were Progyny’s earnings last quarter?
Progyny released its earnings results on May 09, 2024. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.132 by $0.038.
Is Progyny overvalued?
According to Wall Street analysts Progyny’s price is currently Undervalued.
Does Progyny pay dividends?
Progyny does not currently pay dividends.
What is Progyny’s EPS estimate?
Progyny’s EPS estimate is $0.17.
How many shares outstanding does Progyny have?
Progyny has 95,220,690 shares outstanding.
What happened to Progyny’s price movement after its last earnings report?
Progyny reported an EPS of $0.17 in its last earnings report, beating expectations of $0.132. Following the earnings report the stock price went down -15.292%.
Which hedge fund is a major shareholder of Progyny?
Among the largest hedge funds holding Progyny’s share is Crestwood Capital Management, L.P.. It holds Progyny’s shares valued at 17M.
---
Progyny Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$37.75 (34.39% Upside)
$37.75 (34.39% Upside)
Blogger Sentiment
Bullish
PGNY Sentiment 85%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 128.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.3%
Last 30 Days ▼ 0.6%
Last 30 Days ▼ 0.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.85%
12-Months-Change
Fundamentals
Return on Equity
12.30%
Trailing 12-Months
Asset Growth
22.25%
Trailing 12-Months
Company Description
Progyny
Progyny, Inc. is a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools. Its services include egg freezing, IVF treatment, surrogacy, podcast, adoption, and Eeva Test. The company was founded on April 03, 2008 and is headquartered in New York, NY.
---
PGNY Earnings Call
Q1 2024
0:00 / 0:00
---
PGNY Stock 12 Month Forecast
Average Price Target
$37.75
▲(34.39% Upside)
Technical Analysis
Best Analysts Covering PGNY
1 Year
1 Year Success Rate
4/14 ratings generated profit
1 Year Average Return
-12.11%
reiterated a buy rating 11 days ago
Copying Michael Cherny's trades and holding each position for 1 Year would result in 28.57% of your transactions generating a profit, with an average return of -12.11% per trade.
---